FINEOS Corporation Lands Outstanding Achievement in International Growth Award at the Technology Ireland Industry Awards 2020

DUBLIN–(BUSINESS WIRE)–FINEOS Corporation (ASX: FCL), the leading core platform for life, accident and health insurance, headquartered in Ireland and employing over 1000 employees globally, was named winner of the Technology Ireland Outstanding Achievement in International Growth Award at the 28th Annual Technology Ireland Industry Awards last week. The event was supported by platinum sponsors EY and gold sponsors Fidelity Investments, Workhuman, and Enterprise Ireland.

FINEOS Corporation, a global software company providing modern customer-centric core software to the life, accident and health industry, was the overall winner among five companies shortlisted for the award. The company has over 50 customers globally, representing some of the premier names in the insurance industry. Other award winners on the night were Fenergo, Swift Comply, City Swift, TEKenable, VMware, AWS, Microsoft (DreamSpace) and NearForm Covid 19 Tracker.

Commenting on the win, Michael Kelly, CEO of FINEOS, said, “We are thrilled to be recognized

Read More

MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding

CEDAR KNOLLS, N.J., Nov. 17, 2020 /PRNewswire/ — MYOS RENS Technology Inc. (“MYOS” or the “Company”) (NASDAQ: MYOS)

As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Nevada corporation (“MYOS”), and MedAvail, Inc., a privately-held Delaware corporation (“MedAvail”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), by and among MYOS, MedAvail, and Matrix Merger Sub, Inc., a newly-created wholly-owned subsidiary of MYOS (“Merger Sub”), pursuant to which, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into MedAvail, with MedAvail being the surviving corporation and a wholly-owned subsidiary of MYOS (the “Merger”). In addition, prior to the Merger, MYOS will contribute substantially all its assets and liabilities to a wholly owned subsidiary, MYOS Corp., a Delaware corporation (“MYOS Corp.”) in exchange for all the outstanding shares of common stock of

Read More